Evaluation of a new commercial enzyme immunoassay for the detection of IgM antibodies to West Nile virus using a ratio method to eliminate nonspecific reactivity

Journal of Clinical Laboratory Analysis

Volumn 22, Issue 5, 2008, Pages 362-366

  Welch, Ryan J ^a   Anderson, Brian L ^b   Litwin, Christine M ^a,b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

ELISA; Immunology; Serology; West Nile virus

Indexed keywords

HETEROPHILE ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; RHEUMATOID FACTOR;

ANALYTIC METHOD; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FALSE POSITIVE RESULT; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; NONHUMAN; SENSITIVITY AND SPECIFICITY; WEST NILE FLAVIVIRUS;

ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOGLOBULIN M; LINEAR MODELS; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; WEST NILE FEVER; WEST NILE VIRUS;

WEST NILE VIRUS;

EID: 53549114804     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20271     Document Type: Article

References (18)

1. Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ. West Nile virus. Lancet Infect Dis 2002;2:519-529.
2. Guharoy R, Gilroy SA, Noviasky JA, Ference J. West Nile virus infection. Am J Health Syst Pharm 2004;61:1235-1241.
3. Smithburn KC, Hughes TP, Burke AW, Paul JH. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg 1940;20:471-492.
4. Nash D, Mostashari F, Fine A et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001;344:1807-1814.
5. Malkinson M, Banet C, Weisman Y et al. Introduction of West Nile virus in the Middle East by migrating white storks. Emerg Infect Dis 2002;8:392-397.
6. Rappole JH, Derrickson SR, Hubalek Z. Migratory birds and spread of West Nile virus in the Western Hemisphere. Emerg Infect Dis 2000;6:319-328.
7. Turell MJ, Sardelis MR, O'Guinn ML, Dohm DJ. Potential vectors of West Nile virus in North America. Curr Top Microbiol Immunol 2002;267:241-252.
8. CDC. 2003. Epidemic/epizootic West Nile virus in the United States: Guidelines for surveillance. Prevention and Control. p 25.
9. Roehrig JT, Nash D, Maldin B et al. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 2003;9:376-379.
10. Hogrefe WR, Moore R, Lape-Nixon M, Wagner M, Prince HE. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies. J Clin Microbiol 2004;42:4641-4648.
11. Huebner J. 2004. Antibody-antigen interactions and measurements of immunologic reactions. In: GB Pier, L Wetzler, editors. Immunology, infection and immunity. Washington, DC: ASM Press. p 207-232.
12. Kim M, Wadke M. Comparative evaluation of two test methods (enzyme immunoassay and latex fixation) for the detection of heterophil antibodies in infectious mononucleosis. J Clin Microbiol 1990;28:2511-2513.
13. Levinson SS, Miller JJ. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin Chim Acta 2002;325:1-15.
14. Prince HE, Hogrefe WR. Performance characteristics of an inhouse assay system used to detect West Nile Virus (WNV)-specific immunoglobulin M during the 2001 WNV season in the United States. Clin Diagn Lab Immunol 2003;10:177-179.
15. Fleiss JL. 1981. Statistical Methods for Rates and Proportions. New York: Wiley.
16. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999;45:942-956.
17. Salonen EM, Vaheri A, Suni J, Wager O. Rheumatoid factor in acute viral infections: Interference with determination of IgM, IgG, and IgA antibodies in an enzyme immunoassay. J Infect Dis 1980;142:250-255.
18. Sambol AR, Hinrichs SH, Hogrefe WR, Schweitzer BK. Performance of a commercial flavivirus (West Nile) IgM capture analyte specific reagents assay using a screening test for interfering factors (IF) during a West Nile virus epidemic season in Nebraska. Clin Vaccine Immunol 2006;14:87-89.